The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Yunus Kuijpers(Medizinische Hochschule Hannover), Cheng‐Jian Xu(University Medical Center Groningen), Vera P. Mourits(Radboud University Nijmegen), Valerie A. C. M. Koeken(Radboud University Nijmegen), Simone J.C.F.M. Moorlag(Radboud University Medical Center), Nico Janssen(Radboud University Nijmegen), Mihai G. Netea(Radboud University Nijmegen), Quirijn de Mast(Radboud University Nijmegen), Leo A. B. Joosten(Radboud University Nijmegen), Xiaojing Chu(Beijing Normal University), Aline de Nooijer(Radboud University Nijmegen), Frank L. van de Veerdonk(University Medical Center), Manoj Kumar Gupta(Medizinische Hochschule Hannover), Martin Jaeger(Radboud University Nijmegen), Bowen Zhang(Medizinische Hochschule Hannover), L. Charlotte J. de Bree(Radboud University Nijmegen), Yang Li(Union Hospital), Inge Grondman(Radboud University Nijmegen)
Cited by 10
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis
|The American Journal of Human Genetics|2016|921